Lactobacillus crispatus clinical trials
How each study uses lactobacillus crispatus is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the lactobacillus crispatus studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Lactobacillus Crispatus
- 1
Studies by the year they started
4 studies that test it; most in 2026 (2)
| Year | Studies |
|---|---|
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 3
Cultech Ltd (1) · First Affiliated Hospital of Chongqing Medical University (1) · Medstar Health Research Institute (1) · Chang Gung Memorial Hospital (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test lactobacillus crispatus.
- Mar 2027Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome EvaluationEarly Phase 1 · Medstar Health Research Institute
Studies
Open first, then newest update. How each study uses lactobacillus crispatus is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With DepressionRecruitingPhase 2First Affiliated Hospital of Chongqing Medical UniversityNCT07539805Written as Sertraline combined with Lactobacillus crispatus
- Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome EvaluationRecruitingEarly Phase 1Medstar Health Research InstituteNCT07308808Written as Lactobacillus Crispatus
- The Influence of Oral Probiotic on the Vaginal Flora and Microenvironment Alteration in the Vaginosis Infection WomenRecruitingNot applicableChang Gung Memorial HospitalNCT06001190Written as probiotic:Lactobacillus crispatus
- Probiotics for WomenCompletedNot applicableCultech LtdNCT07364383Written as Lab4 + Lactobacillus gasseri and Lactobacillus crispatus
Codes
What other systems call lactobacillus crispatus · ClinicalTrials.gg INT017722
- RxNorm 2054188One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 2054188 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.